Diego Cadavid - Net Worth and Insider Trading
Diego Cadavid Net Worth
The estimated net worth of Diego Cadavid is at least $227,042 dollars as of 2024-09-20. Diego Cadavid is the SVP Clinical Development of Fulcrum Therapeutics Inc and owns about 65,714 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $227,042. Details can be seen in Diego Cadavid's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Diego Cadavid has not made any transactions after 2020-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Diego Cadavid
Diego Cadavid Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Diego Cadavid owns 2 companies in total, including Fulcrum Therapeutics Inc (FULC) , and X4 Pharmaceuticals Inc (XFOR) .
Click here to see the complete history of Diego Cadavid’s form 4 insider trades.
Insider Ownership Summary of Diego Cadavid
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2020-07-01 | SVP Clinical Development |
| XFOR | X4 Pharmaceuticals Inc | 2020-12-14 | Chief Medical Officer |
Diego Cadavid Latest Holdings Summary
Diego Cadavid currently owns a total of 1 stock. Diego Cadavid owns 65,714 shares of Fulcrum Therapeutics Inc (FULC) as of July 1, 2020, with a value of $227,042.
Latest Holdings of Diego Cadavid
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2020-07-01 | 65,714 | 3.46 | 227,042 |
Holding Weightings of Diego Cadavid
Diego Cadavid Form 4 Trading Tracker
According to the SEC Form 4 filings, Diego Cadavid has made a total of 9 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 1,071 shares on July 1, 2020, which brought Diego Cadavid around $19,599.
Insider Trading History of Diego Cadavid
- 1
Diego Cadavid Trading Performance
Diego Cadavid Ownership Network
Diego Cadavid Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Diego Cadavid is the SVP Clinical Development of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Diego Cadavid made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,330 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,030 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Diego Cadavid Mailing Address
Above is the net worth, insider trading, and ownership report for Diego Cadavid. You might contact Diego Cadavid via mailing address: C/o Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
